Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 3:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (50.0%)Phase 4
1 (50.0%)Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension
Phase 3
Completed
- Conditions
- Pulmonary Hypertension
- First Posted Date
- 2004-04-05
- Last Posted Date
- 2007-11-09
- Lead Sponsor
- Encysive Pharmaceuticals
- Target Recruit Count
- 240
- Registration Number
- NCT00080457
- Locations
- 🇺🇸
Encysive Pharmaceuticals, Houston, Texas, United States
Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin
Phase 4
Completed
- Conditions
- ThrombocytopeniaThrombosis
- First Posted Date
- 2002-06-14
- Last Posted Date
- 2007-01-11
- Lead Sponsor
- Encysive Pharmaceuticals
- Target Recruit Count
- 24
- Registration Number
- NCT00039858
- Locations
- 🇺🇸
Mattel Children's Hospital at UCLA, Los Angeles, California, United States
🇺🇸Children's Hospital of Orange County, Orange, California, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
News
No news found